Click for best price
Crohn?s Disease Drugs Market Size, Share 2024
This research report provides a comprehensive analysis of the Crohn?s Disease Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Crohn?s Disease Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Crohn?s Disease Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Crohn?s Disease Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Crohn?s Disease Drugs market presents opportunities for various stakeholders, including Hospitals, Clinics. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Crohn?s Disease Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Crohn?s Disease Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Crohn?s Disease Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Crohn?s Disease Drugs market.
Market Overview: The report provides a comprehensive overview of the Crohn?s Disease Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Anti-Inflammatory, Immune system suppressors), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Crohn?s Disease Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Crohn?s Disease Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Crohn?s Disease Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Crohn?s Disease Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Crohn?s Disease Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Crohn?s Disease Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Crohn?s Disease Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Crohn?s Disease Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Crohn?s Disease Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Anti-Inflammatory
Immune system suppressors
Antibiotics
Others
Market segment by Application
Hospitals
Clinics
Hospitalshospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Crohn?s Disease Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Bayer AG
Amgen
Takeda Pharmaceutical
AbbVie
UCB
Ferring
Eli Lilly
Hoffman-La Roche
Bristol-Myers Squibb
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Crohn?s Disease Drugs, market overview.
Chapter 2: Global Crohn?s Disease Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Crohn?s Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Crohn?s Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Crohn?s Disease Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Crohn?s Disease Drugs Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
117 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Crohn?s Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Crohn?s Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Crohn?s Disease Drugs Overall Market Size
2.1 Global Crohn?s Disease Drugs Market Size: 2023 VS 2030
2.2 Global Crohn?s Disease Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Crohn?s Disease Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Crohn?s Disease Drugs Players in Global Market
3.2 Top Global Crohn?s Disease Drugs Companies Ranked by Revenue
3.3 Global Crohn?s Disease Drugs Revenue by Companies
3.4 Global Crohn?s Disease Drugs Sales by Companies
3.5 Global Crohn?s Disease Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Crohn?s Disease Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Crohn?s Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Crohn?s Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Crohn?s Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Crohn?s Disease Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Crohn?s Disease Drugs Market Size Markets, 2023 & 2030
4.1.2 Anti-Inflammatory
4.1.3 Immune system suppressors
4.1.4 Antibiotics
4.1.5 Others
4.2 By Type - Global Crohn?s Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Crohn?s Disease Drugs Revenue, 2019-2024
4.2.2 By Type - Global Crohn?s Disease Drugs Revenue, 2025-2030
4.2.3 By Type - Global Crohn?s Disease Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Crohn?s Disease Drugs Sales & Forecasts
4.3.1 By Type - Global Crohn?s Disease Drugs Sales, 2019-2024
4.3.2 By Type - Global Crohn?s Disease Drugs Sales, 2025-2030
4.3.3 By Type - Global Crohn?s Disease Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Crohn?s Disease Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Crohn?s Disease Drugs Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Hospitalshospital Pharmacies
5.1.5 Retail Pharmacies
5.1.6 Online Pharmacies
5.2 By Application - Global Crohn?s Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Crohn?s Disease Drugs Revenue, 2019-2024
5.2.2 By Application - Global Crohn?s Disease Drugs Revenue, 2025-2030
5.2.3 By Application - Global Crohn?s Disease Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Crohn?s Disease Drugs Sales & Forecasts
5.3.1 By Application - Global Crohn?s Disease Drugs Sales, 2019-2024
5.3.2 By Application - Global Crohn?s Disease Drugs Sales, 2025-2030
5.3.3 By Application - Global Crohn?s Disease Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Crohn?s Disease Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Crohn?s Disease Drugs Market Size, 2023 & 2030
6.2 By Region - Global Crohn?s Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Crohn?s Disease Drugs Revenue, 2019-2024
6.2.2 By Region - Global Crohn?s Disease Drugs Revenue, 2025-2030
6.2.3 By Region - Global Crohn?s Disease Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Crohn?s Disease Drugs Sales & Forecasts
6.3.1 By Region - Global Crohn?s Disease Drugs Sales, 2019-2024
6.3.2 By Region - Global Crohn?s Disease Drugs Sales, 2025-2030
6.3.3 By Region - Global Crohn?s Disease Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Crohn?s Disease Drugs Revenue, 2019-2030
6.4.2 By Country - North America Crohn?s Disease Drugs Sales, 2019-2030
6.4.3 US Crohn?s Disease Drugs Market Size, 2019-2030
6.4.4 Canada Crohn?s Disease Drugs Market Size, 2019-2030
6.4.5 Mexico Crohn?s Disease Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Crohn?s Disease Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Crohn?s Disease Drugs Sales, 2019-2030
6.5.3 Germany Crohn?s Disease Drugs Market Size, 2019-2030
6.5.4 France Crohn?s Disease Drugs Market Size, 2019-2030
6.5.5 U.K. Crohn?s Disease Drugs Market Size, 2019-2030
6.5.6 Italy Crohn?s Disease Drugs Market Size, 2019-2030
6.5.7 Russia Crohn?s Disease Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Crohn?s Disease Drugs Market Size, 2019-2030
6.5.9 Benelux Crohn?s Disease Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Crohn?s Disease Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Crohn?s Disease Drugs Sales, 2019-2030
6.6.3 China Crohn?s Disease Drugs Market Size, 2019-2030
6.6.4 Japan Crohn?s Disease Drugs Market Size, 2019-2030
6.6.5 South Korea Crohn?s Disease Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Crohn?s Disease Drugs Market Size, 2019-2030
6.6.7 India Crohn?s Disease Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Crohn?s Disease Drugs Revenue, 2019-2030
6.7.2 By Country - South America Crohn?s Disease Drugs Sales, 2019-2030
6.7.3 Brazil Crohn?s Disease Drugs Market Size, 2019-2030
6.7.4 Argentina Crohn?s Disease Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Crohn?s Disease Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Crohn?s Disease Drugs Sales, 2019-2030
6.8.3 Turkey Crohn?s Disease Drugs Market Size, 2019-2030
6.8.4 Israel Crohn?s Disease Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Crohn?s Disease Drugs Market Size, 2019-2030
6.8.6 UAE Crohn?s Disease Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Crohn?s Disease Drugs Major Product Offerings
7.1.4 Bayer AG Crohn?s Disease Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Bayer AG Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Crohn?s Disease Drugs Major Product Offerings
7.2.4 Amgen Crohn?s Disease Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Amgen Key News & Latest Developments
7.3 Takeda Pharmaceutical
7.3.1 Takeda Pharmaceutical Company Summary
7.3.2 Takeda Pharmaceutical Business Overview
7.3.3 Takeda Pharmaceutical Crohn?s Disease Drugs Major Product Offerings
7.3.4 Takeda Pharmaceutical Crohn?s Disease Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Takeda Pharmaceutical Key News & Latest Developments
7.4 AbbVie
7.4.1 AbbVie Company Summary
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Crohn?s Disease Drugs Major Product Offerings
7.4.4 AbbVie Crohn?s Disease Drugs Sales and Revenue in Global (2019-2024)
7.4.5 AbbVie Key News & Latest Developments
7.5 UCB
7.5.1 UCB Company Summary
7.5.2 UCB Business Overview
7.5.3 UCB Crohn?s Disease Drugs Major Product Offerings
7.5.4 UCB Crohn?s Disease Drugs Sales and Revenue in Global (2019-2024)
7.5.5 UCB Key News & Latest Developments
7.6 Ferring
7.6.1 Ferring Company Summary
7.6.2 Ferring Business Overview
7.6.3 Ferring Crohn?s Disease Drugs Major Product Offerings
7.6.4 Ferring Crohn?s Disease Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Ferring Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Company Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Crohn?s Disease Drugs Major Product Offerings
7.7.4 Eli Lilly Crohn?s Disease Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 Hoffman-La Roche
7.8.1 Hoffman-La Roche Company Summary
7.8.2 Hoffman-La Roche Business Overview
7.8.3 Hoffman-La Roche Crohn?s Disease Drugs Major Product Offerings
7.8.4 Hoffman-La Roche Crohn?s Disease Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Hoffman-La Roche Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Crohn?s Disease Drugs Major Product Offerings
7.9.4 Bristol-Myers Squibb Crohn?s Disease Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Crohn?s Disease Drugs Major Product Offerings
7.10.4 Pfizer Crohn?s Disease Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Pfizer Key News & Latest Developments
8 Global Crohn?s Disease Drugs Production Capacity, Analysis
8.1 Global Crohn?s Disease Drugs Production Capacity, 2019-2030
8.2 Crohn?s Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Crohn?s Disease Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Crohn?s Disease Drugs Supply Chain Analysis
10.1 Crohn?s Disease Drugs Industry Value Chain
10.2 Crohn?s Disease Drugs Upstream Market
10.3 Crohn?s Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Crohn?s Disease Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Crohn?s Disease Drugs in Global Market
Table 2. Top Crohn?s Disease Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Crohn?s Disease Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Crohn?s Disease Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Crohn?s Disease Drugs Sales by Companies, (K Units), 2019-2024
Table 6. Global Crohn?s Disease Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Crohn?s Disease Drugs Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Crohn?s Disease Drugs Product Type
Table 9. List of Global Tier 1 Crohn?s Disease Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Crohn?s Disease Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Crohn?s Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Crohn?s Disease Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Crohn?s Disease Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Crohn?s Disease Drugs Sales (K Units), 2019-2024
Table 15. By Type - Global Crohn?s Disease Drugs Sales (K Units), 2025-2030
Table 16. By Application ? Global Crohn?s Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Crohn?s Disease Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Crohn?s Disease Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Crohn?s Disease Drugs Sales (K Units), 2019-2024
Table 20. By Application - Global Crohn?s Disease Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global Crohn?s Disease Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Crohn?s Disease Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Crohn?s Disease Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Crohn?s Disease Drugs Sales (K Units), 2019-2024
Table 25. By Region - Global Crohn?s Disease Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Crohn?s Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Crohn?s Disease Drugs Sales, (K Units), 2019-2024
Table 29. By Country - North America Crohn?s Disease Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Crohn?s Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Crohn?s Disease Drugs Sales, (K Units), 2019-2024
Table 33. By Country - Europe Crohn?s Disease Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Crohn?s Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Crohn?s Disease Drugs Sales, (K Units), 2019-2024
Table 37. By Region - Asia Crohn?s Disease Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Crohn?s Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Crohn?s Disease Drugs Sales, (K Units), 2019-2024
Table 41. By Country - South America Crohn?s Disease Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Crohn?s Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Crohn?s Disease Drugs Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Crohn?s Disease Drugs Sales, (K Units), 2025-2030
Table 46. Bayer AG Company Summary
Table 47. Bayer AG Crohn?s Disease Drugs Product Offerings
Table 48. Bayer AG Crohn?s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Bayer AG Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Crohn?s Disease Drugs Product Offerings
Table 52. Amgen Crohn?s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Amgen Key News & Latest Developments
Table 54. Takeda Pharmaceutical Company Summary
Table 55. Takeda Pharmaceutical Crohn?s Disease Drugs Product Offerings
Table 56. Takeda Pharmaceutical Crohn?s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Takeda Pharmaceutical Key News & Latest Developments
Table 58. AbbVie Company Summary
Table 59. AbbVie Crohn?s Disease Drugs Product Offerings
Table 60. AbbVie Crohn?s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. AbbVie Key News & Latest Developments
Table 62. UCB Company Summary
Table 63. UCB Crohn?s Disease Drugs Product Offerings
Table 64. UCB Crohn?s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. UCB Key News & Latest Developments
Table 66. Ferring Company Summary
Table 67. Ferring Crohn?s Disease Drugs Product Offerings
Table 68. Ferring Crohn?s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Ferring Key News & Latest Developments
Table 70. Eli Lilly Company Summary
Table 71. Eli Lilly Crohn?s Disease Drugs Product Offerings
Table 72. Eli Lilly Crohn?s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Eli Lilly Key News & Latest Developments
Table 74. Hoffman-La Roche Company Summary
Table 75. Hoffman-La Roche Crohn?s Disease Drugs Product Offerings
Table 76. Hoffman-La Roche Crohn?s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Hoffman-La Roche Key News & Latest Developments
Table 78. Bristol-Myers Squibb Company Summary
Table 79. Bristol-Myers Squibb Crohn?s Disease Drugs Product Offerings
Table 80. Bristol-Myers Squibb Crohn?s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Bristol-Myers Squibb Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Crohn?s Disease Drugs Product Offerings
Table 84. Pfizer Crohn?s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Pfizer Key News & Latest Developments
Table 86. Crohn?s Disease Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 87. Global Crohn?s Disease Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Crohn?s Disease Drugs Production by Region, 2019-2024 (K Units)
Table 89. Global Crohn?s Disease Drugs Production by Region, 2025-2030 (K Units)
Table 90. Crohn?s Disease Drugs Market Opportunities & Trends in Global Market
Table 91. Crohn?s Disease Drugs Market Drivers in Global Market
Table 92. Crohn?s Disease Drugs Market Restraints in Global Market
Table 93. Crohn?s Disease Drugs Raw Materials
Table 94. Crohn?s Disease Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Crohn?s Disease Drugs Downstream
Table 96. Crohn?s Disease Drugs Downstream Clients in Global Market
Table 97. Crohn?s Disease Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Crohn?s Disease Drugs Segment by Type in 2023
Figure 2. Crohn?s Disease Drugs Segment by Application in 2023
Figure 3. Global Crohn?s Disease Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Crohn?s Disease Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Crohn?s Disease Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Crohn?s Disease Drugs Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Crohn?s Disease Drugs Revenue in 2023
Figure 9. By Type - Global Crohn?s Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Crohn?s Disease Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Crohn?s Disease Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Crohn?s Disease Drugs Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Crohn?s Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Crohn?s Disease Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Crohn?s Disease Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Crohn?s Disease Drugs Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Crohn?s Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Crohn?s Disease Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Crohn?s Disease Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Crohn?s Disease Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Crohn?s Disease Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Crohn?s Disease Drugs Sales Market Share, 2019-2030
Figure 23. US Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Crohn?s Disease Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Crohn?s Disease Drugs Sales Market Share, 2019-2030
Figure 28. Germany Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Crohn?s Disease Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Crohn?s Disease Drugs Sales Market Share, 2019-2030
Figure 37. China Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Crohn?s Disease Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Crohn?s Disease Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Crohn?s Disease Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Crohn?s Disease Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Crohn?s Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Crohn?s Disease Drugs Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Crohn?s Disease Drugs by Region, 2023 VS 2030
Figure 54. Crohn?s Disease Drugs Industry Value Chain
Figure 55. Marketing Channels
